Von Seggern Christopher 4
4 · Xenon Pharmaceuticals Inc. · Filed Dec 7, 2021
Insider Transaction Report
Form 4
Von Seggern Christopher
Chief Commercial Officer
Transactions
- Purchase
Common Shares
2021-12-06$24.40/sh+4,000$97,600→ 4,000 total
4 · Xenon Pharmaceuticals Inc. · Filed Dec 7, 2021
Common Shares